The Flexner Report: A 1910 Blueprint for Modern Pharma’s Oil Foundations
Is it just a coincidence that shortly after Professor Abraham Flexner’s report revolutionized American medicine, substances derived from oil became its cornerstone? His influential document effectively dismantled traditional medical practices, paving the way for what is now known as “Big Pharma.”
This transformation saw older forms of healthcare dismissed and often forced out. Medical offices resisting change found their doors closing, largely due to government funding mechanisms tied to Flexner’s new standards.
The Pathology Report reveals that this shift towards petroleum-based solutions was not an organic development but strategically driven by powerful interests intertwined with industries like oil and finance – a system designed for perpetual medical consumption rather than true healing.
However, a compelling alternative narrative emerges. One entity chose a different path: turning away from the synthetic petrochemical approach championed by Flexner’s report.
Their product offers rapid pain relief in mere minutes, placing significant power back into patients’ hands against the backdrop of institutionalized pharmaceutical dependency.
This innovation challenges the very foundation established by the Flexner Report – demonstrating that effective treatments don’t necessarily need to be oil-derived. As we await further developments in this space, it’s worth noting: conventional medicine relies heavily on patented chemicals often connected to fossil fuel interests, while alternative solutions might circumvent these restrictive patents entirely.
The evidence suggests that true medical progress requires looking beyond the limitations Flexner imposed – limitations that fundamentally changed healthcare into a system centered around oil and money.